Talenom Oyj

Talenom's capital structure is characterized by a lack of dilution risk, as shares outstanding remain unchanged at 45.48 million in both basic and diluted terms. However, liquidity risk could not be assessed due to missing balance-sheet inputs and no going-concern language in source documents. The company's valuation snapshot is incomplete, precluding direct comparisons to industry medians for metrics like ROIC or EBITDA margins. Profitability metrics are not available in the current dataset, preventing a direct comparison to industry_config preferred metrics for Business Support Services. Without disclosed revenue, net income, or operating cash flow figures, it is impossible to evaluate Talenom's returns relative to cohort medians or industry benchmarks. Segment and geographic exposure data are not disclosed in the input, making it impossible to assess revenue concentration or geographic diversification. The company operates in Finland and internationally, but no specific segment or regional revenue breakdown is available for analysis. Growth trajectory data is absent from the input, with no revenue history or outlook numeric deltas provided. Analysts have issued a single "strong buy" recommendation with a consensus price target of 1.80 EUR, but no forward-looking revenue or margin guidance is available to support this assessment. Risk factors include the inability to assess liquidity risk due to missing balance-sheet data. Dilution risk is currently low, as no adjustments have been applied to shares outstanding. However, the absence of financial disclosures limits the ability to evaluate credit risk or operational resilience. Recent events include the publication of analyst estimates with a strong buy recommendation, but no specific filings or transcripts are cited in the input data to support further analysis of management commentary or strategic direction.